Press release from Companies
Published: 2025-08-22 10:43:35
The shareholders of Eevia Health Plc, company registration number 2825194-4 in Finland, are hereby called for the Annual General Meeting (AGM) to be held on September 15th, 2025. The AGM will be held at 12:00 Finnish time at the main office of Eevia Health Plc in Koulukatu 14, 60100 Seinäjoki, Finland. The venue will be open from 11:30.
The Board of Directors proposes that the net loss is transferred to retained earnings/loss account and that no dividend be paid.
The Shareholders’ Nomination Board has proposed that five (5) members be elected to the Board of Directors, which is within the limits of the company’s current Articles of Association.
The term of office will continue until the next Annual General Meeting as stipulated in the Articles of Association.
The remuneration was decided by the EGM on November 4, 2024, and should only be restated in the AGM
The Board of Directors proposes that the auditor’s fees be paid according to the auditor’s reasonable invoice approved by the company.
The financial statements of Eevia Health Abp and the auditor’s report are not finalized yet and will be published soon. The documentation on the proposals, including proposal and documentation for item nr 10, is also not ready as of today, but is expected to be finalized shortly and published. However, due to the expediency of the issue under item 10, the call is made now without providing the mentioned documents. The Company will publish these through a press release and make them available to the General Meeting on Eevia Health Abp’s website. The meeting is called for September 15th to allow for the delayed publishing of these documents.
The documents mentioned above will also be available at the meeting. Minutes of the General Meeting are available on the above-mentioned website from 17th September 2024 at the latest.
Each shareholder who is registered on the 2 September 2025 at 16:00, EEST (Finnish time) at the latest in the shareholders’ register of the company held by Euroclear Finland Ltd., has the right to participate in the General Meeting. A shareholder, whose shares are registered on his/her/its personal Finnish book-entry account, is registered in the shareholders’ register of the company.
A shareholder, who wants to participate in the General Meeting, shall register for the meeting no later than 10 September 2025 at 10.00, EEST (Finnish time) by which time the registration shall be received. Shareholders who have a Finnish book-entry account may register by the following means:
a) Through email: info@eeviahealth.com
b) by regular mail: to Eevia Health Plc, General Meeting, Koulukatu 14, 60100 Seinäjoki, Finland.
Requested information shall be given in connection with the registration such as name, personal identification number, address, email address and the name of a possible assistant or proxy representative, and the personal identification number of a proxy representative. The personal data given to Eevia Health Plc is used only in connection with the General Meeting and the processing of related necessary registrations and for shareholder communication. Shareholder, his/her/its representative or proxy representative shall, when necessary, be able to prove his/her/its identity and/or right of representation.
A holder of nominee-registered shares has the right to participate in the General Meeting by virtue of shares based on which he/she/it on the record date of the meeting, on 2 September 2025, 16:00 EEST (Finnish time) the latest, would be entitled to be registered in the shareholders’ register of the company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder has been registered into the temporary shareholders’ register of the company held by Euroclear Finland Ltd. at the latest on 10 September 2025 by 10:00, EEST (Finnish time). As regards nominee-registered shares this constitutes due registration for the General Meeting.
A holder of nominee-registered shares is advised without delay to request necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the General Meeting from his/her/its custodian bank. The account management organization of the custodian bank must register a holder of nominee-registered shares, who wants to participate in the General Meeting, into the temporary shareholders’ register of the company at the latest on the date and time mentioned above.
Shareholder whose shares are registered in the securities system of Euroclear Sweden AB and who wants to participate in the General Meeting and use his/her/its voting right, shall be registered at the shareholder’s register held by Euroclear Sweden AB on 2 September 2025 17:00 CEST (Swedish time) at the latest.
To be entitled to request for temporary registration in the shareholder’s register of Eevia Health Abp. held by Euroclear Finland Ltd., a shareholder of nominee-registered shares shall request that his/her/its shares are temporarily registered under his/her/its own name in the shareholder’s register held by Euroclear Sweden AB and to ensure that the custodian bank will send the above-mentioned request for temporary registration to Euroclear Sweden AB. The registration shall be made on 2 September 2025, 17:00 CEST (Swedish time) at the latest, and therefore a shareholder shall give the request to his/her/its custodian bank in good time prior to the above date.
Shareholder, whose shares are registered in the securities system of Euroclear Sweden AB and who intends to participate in the General Meeting and use his/her/its voting right, shall request for a temporary registration of his/her shares to the shareholder’s register of Eevia Health Plc held by Euroclear Finland Oy. The request to Eevia Health Abp shall be made in writing at the latest on 10 September 2025, 10:00 Swedish time. The temporary registration through Eevia Health Abp. constitutes a due registration to the General Meeting.
A shareholder may participate in the General Meeting and exercise his/her/its rights at the meeting by way of proxy representation.
A proxy representative shall produce a dated proxy document or otherwise provide reliable evidence of the right to represent the shareholder. The authorization applies to one meeting unless otherwise stated. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting.
If you do not have access to a person who is able and willing to meet with your proxy, such proxy can also be given to Stein Ulve (sten.ulve@eeviahealth.com). Please inform us by filling his name in the proxy form available on the Company’s website here: https://investor.eeviahealth.com/corporate-governance/general-meetings/2024/ and send it to info@eeviahealth.com.
Proxy documents should be delivered via email to info@eeviahealth.com by 11:00 am EEST (Finnish time) on September 15th, 2025, at the latest, or have your proxy representative bring them to the AGM.
Pursuant to Chapter 5 Section 25 of the Finnish Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be handled at the meeting.
On the date of the notice to the General Meeting, 22 August 2025, the total number of shares in Eevia Health Plc is 126,842,805. Each share carries one vote at the General Meeting.
Seinäjoki, 22 August 2025
EEVIA HEALTH ABP
Board of Directors
For further information, please contact:
Stein Ulve, CEO, Eevia Health Abp
Email: stein.ulve@eeviahealth.com
Telephone: +358 400 22 5967
Information about Eevia Health
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Most of Eevia's raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild harvested in a sustainable fashion.
A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
